Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 2Phase NA 1Phase 2/3 1

Status

Completed 2Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Esophageal Neoplasms 25Rectal Neoplasms 23Glioblastoma 23Prostatic Neoplasms 19Carcinoma, Non-Small-Cell Lung 17Breast Neoplasms 17Pancreatic Neoplasms 16Lung Neoplasms 16Squamous Cell Carcinoma of Head and Neck 14Head and Neck Neoplasms 14Neoplasms 12Oropharyngeal Neoplasms 11Neoplasm Metastasis 10Esophageal Squamous Cell Carcinoma 9Adenocarcinoma Of Esophagus 8Uterine Cervical Neoplasms 7Glioma 7Triple Negative Breast Neoplasms 6Stomach Neoplasms 6Gliosarcoma 6Carcinoma, Squamous Cell 6Brain Neoplasms 6Urinary Bladder Neoplasms 5Nasopharyngeal Carcinoma 5Melanoma 5Laryngeal Neoplasms 5Colorectal Neoplasms 5Xerostomia 4Sarcoma 4Mouth Neoplasms 4

Interventions

Fluorouracil 13Cisplatin 7Radiotherapy 6Specimen Handling 5Mitomycin 5Capecitabine 5pembrolizumab 4dehydroftorafur 4Radiation 4Drug Therapy 4Cetuximab 4Radiotherapy, Intensity-Modulated 3Paclitaxel 3Nivolumab 3Magnetic Resonance Spectroscopy 3Carboplatin 3Biopsy 3tislelizumab 2durvalumab 2aldesleukin 2VGX-3100 2Platinum 2Mitozytrex 2Immune Checkpoint Inhibitors 2Fluorodeoxyglucose F18 21,2-diaminocyclohexaneplatinum II citrate 2toripalimab 1technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 1spartalizumab 1rocakinogene sifuplasmid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Anus Neoplasms × Radiation × Clear all
NCT06493019 2026-03-23

Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer

Hoosier Cancer Research Network

Phase 2 Recruiting
23 enrolled
Gastrointestinal

Anus Neoplasms

NCT05060471 2024-12-03

PD-1 Blockade Combined With Chemotherapy Followed by Concurrent Immunoradiotherapy for Locally Advanced SCCA Patients

Sun Yat-sen University

Phase 2 Completed
25 enrolled
Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

NCT04230759 2024-09-19

RADIANCE

Goethe University

Phase 2 Active not recruiting
180 enrolled
Gastrointestinal

Anus Neoplasms

NCT01285778 2018-05-16

VITAL

Grupo Espanol Multidisciplinario del Cancer Digestivo

Phase 2 Completed
58 enrolled
Gastrointestinal

Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡